Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects | Zendy

Joe A. Vinson | Zendy; Mysore V. Nagendran | Zendy; Bryan R. Burnham | Zendy

Open Access

Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects

Author(s) -

Joe A. Vinson,

Mysore V. Nagendran,

Bryan R. Burnham

Publication year - 2012

Publication title -

diabetes metabolic syndrome and obesity

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.853

H-Index - 43

ISSN - 1178-7007

DOI - 10.2147/dmso.s27665

Subject(s) - overweight , crossover study , body mass index , medicine , placebo , heart rate , obesity , weight loss , body fat percentage , basal metabolic rate , blood pressure , alternative medicine , pathology

Adult weight gain and obesity have become worldwide problems. Issues of cost and potential side effects of prescription weight loss drugs have led overweight and obese adults to try nutraceuticals that may aid weight loss. One promising nutraceutical is green coffee extract, which contains high concentrations of chlorogenic acids that are known to have health benefits and to influence glucose and fat metabolism. A 22-week crossover study was conducted to examine the efficacy and safety of a commercial green coffee extract product GCA™ at reducing weight and body mass in 16 overweight adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research